Skip to main content

DAVENPORT & Co LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 887777 RICHMOND, VA

Position in REGN

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$338,582
-$38,466 QoQ
Shares Held
543
+11.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#907
of 1,322 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAVENPORT & Co LLC holds $137,698,050 across 19 Biotechnology names. REGN ranks #12 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $338,582 543
2026-03-31 $377,048 488
2025-12-31 $281,732 365
2025-06-30 $206,850 394
2025-03-31 $270,816 427
2024-09-30 $452,033 430
2024-06-30 $388,881 370
2024-03-31 $435,045 452
2023-12-31 $328,480 374
2023-09-30 $310,255 377
2023-06-30 $2,139,812 2,978
2023-03-31 $3,218,481 3,917
2022-12-31 $3,558,388 4,932
2022-09-30 $3,459,505 5,022
2022-06-30 $2,997,620 5,071
2022-03-31 $3,522,132 5,043
2021-12-31 $3,031,296 4,800
2021-09-30 $1,621,277 2,679
2021-06-30 $300,494 538